Annual Total Long Term Liabilities
$549.00 K
-$126.00 M-99.57%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual total long term liabilities is $549.00 thousand, with the most recent change of -$126.00 million (-99.57%) on December 31, 2021.
- During the last 3 years, IDRA annual total long term liabilities has risen by +$538.00 thousand (+4890.91%).
Performance
IDRA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$63.68 M
+$63.24 M+14439.50%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly total long term liabilities is $63.68 million, with the most recent change of +$63.24 million (+14439.50%) on September 30, 2022.
- Over the past year, IDRA quarterly long term liabilities has increased by +$63.08 million (+10461.03%).
Performance
IDRA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IDRA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -99.6% | +10000.0% |
| 3 y3 years | +4890.9% | +100.0% |
| 5 y5 years | -10.4% | +7365.8% |
IDRA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -99.3% |
| 5 y | 5-year | -99.6% | at low | -49.7% | -99.3% |
| alltime | all time | -99.6% | -99.1% | -49.7% | -100.0% |
Idera Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $63.68 M(>+9900.0%) |
| Jun 2022 | - | $438.00 K(-11.3%) |
| Mar 2022 | - | $494.00 K(-10.0%) |
| Dec 2021 | $549.00 K(-99.6%) | $549.00 K(-9.0%) |
| Sep 2021 | - | $603.00 K(-8.1%) |
| Jun 2021 | - | $656.00 K(-7.3%) |
| Mar 2021 | - | $708.00 K(-99.4%) |
| Dec 2020 | $126.54 M(+2956.6%) | $126.54 M(+118.3%) |
| Sep 2020 | - | $57.97 M(+29.0%) |
| Jun 2020 | - | $44.94 M(+1399.6%) |
| Mar 2020 | - | $3.00 M(-27.6%) |
| Dec 2019 | $4.14 M(>+9900.0%) | $4.14 M(>+9900.0%) |
| Sep 2019 | - | $0.00(-100.0%) |
| Jun 2019 | - | $12.00 K(-77.4%) |
| Mar 2019 | - | $53.00 K(+381.8%) |
| Dec 2018 | $11.00 K(-98.2%) | $11.00 K(-82.5%) |
| Sep 2018 | - | $63.00 K(-83.2%) |
| Jun 2018 | - | $374.00 K(-20.1%) |
| Mar 2018 | - | $468.00 K(-23.7%) |
| Dec 2017 | $613.00 K(+15.9%) | $613.00 K(-28.1%) |
| Sep 2017 | - | $853.00 K(-25.8%) |
| Jun 2017 | - | $1.15 M(+206.7%) |
| Mar 2017 | - | $375.00 K(-29.1%) |
| Dec 2016 | $529.00 K(-71.8%) | $529.00 K(-29.4%) |
| Sep 2016 | - | $749.00 K(-33.4%) |
| Jun 2016 | - | $1.13 M(-25.3%) |
| Mar 2016 | - | $1.51 M(-19.8%) |
| Dec 2015 | $1.88 M(+92.1%) | $1.88 M(+161.0%) |
| Sep 2015 | - | $720.00 K(-12.1%) |
| Jun 2015 | - | $819.00 K(-9.5%) |
| Mar 2015 | - | $905.00 K(-7.5%) |
| Dec 2014 | $978.00 K(>+9900.0%) | $978.00 K(-8.8%) |
| Sep 2014 | - | $1.07 M(+1716.9%) |
| Jun 2014 | - | $59.00 K(+1375.0%) |
| Mar 2014 | - | $4000.00(-20.0%) |
| Dec 2013 | $5000.00(-92.3%) | $5000.00(-16.7%) |
| Sep 2013 | - | $6000.00(-14.3%) |
| Jun 2013 | - | $7000.00(-76.7%) |
| Mar 2013 | - | $30.00 K(-53.8%) |
| Dec 2012 | $65.00 K(-95.8%) | $65.00 K(-99.1%) |
| Sep 2012 | - | $7.09 M(-2.0%) |
| Jun 2012 | - | $7.24 M(-15.6%) |
| Mar 2012 | - | $8.57 M(+447.7%) |
| Dec 2011 | $1.56 M(+552.1%) | $1.56 M(+702.6%) |
| Sep 2011 | - | $195.00 K(-10.1%) |
| Jun 2011 | - | $217.00 K(-6.1%) |
| Mar 2011 | - | $231.00 K(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $240.00 K(-25.0%) | $240.00 K(-15.8%) |
| Sep 2010 | - | $285.00 K(-6.9%) |
| Jun 2010 | - | $306.00 K(-2.9%) |
| Mar 2010 | - | $315.00 K(-1.6%) |
| Dec 2009 | $320.00 K(-97.4%) | $320.00 K(-75.3%) |
| Sep 2009 | - | $1.30 M(-49.2%) |
| Jun 2009 | - | $2.55 M(-62.7%) |
| Mar 2009 | - | $6.85 M(-44.7%) |
| Dec 2008 | $12.38 M(+13.8%) | $12.38 M(-30.9%) |
| Sep 2008 | - | $17.91 M(-23.6%) |
| Jun 2008 | - | $23.43 M(-19.1%) |
| Mar 2008 | - | $28.96 M(+166.2%) |
| Dec 2007 | $10.88 M(-46.4%) | $10.88 M(-10.7%) |
| Sep 2007 | - | $12.18 M(-9.5%) |
| Jun 2007 | - | $13.46 M(-3.3%) |
| Mar 2007 | - | $13.92 M(-31.4%) |
| Dec 2006 | $20.29 M(+223.4%) | $20.29 M(+280.0%) |
| Sep 2006 | - | $5.34 M(+2.5%) |
| Jun 2006 | - | $5.21 M(-9.3%) |
| Mar 2006 | - | $5.74 M(-8.5%) |
| Dec 2005 | $6.27 M(+721.3%) | $6.27 M(-7.8%) |
| Sep 2005 | - | $6.81 M(-7.9%) |
| Jun 2005 | - | $7.39 M(+1050.8%) |
| Mar 2005 | - | $641.80 K(-16.0%) |
| Dec 2004 | $763.70 K(+17.3%) | $763.70 K(+37.5%) |
| Sep 2004 | - | $555.50 K(-5.4%) |
| Jun 2004 | - | $587.40 K(-5.2%) |
| Mar 2004 | - | $619.30 K(-4.9%) |
| Dec 2003 | $651.20 K(-61.0%) | $651.20 K(-4.7%) |
| Sep 2003 | - | $683.10 K(-4.5%) |
| Jun 2003 | - | $715.00 K(-61.4%) |
| Mar 2003 | - | $1.85 M(+11.1%) |
| Dec 2002 | $1.67 M(-93.9%) | $1.67 M(-0.6%) |
| Sep 2002 | - | $1.68 M(-93.2%) |
| Jun 2002 | - | $24.67 M(-7.5%) |
| Mar 2002 | - | $26.66 M(-2.8%) |
| Dec 2001 | $27.44 M(+193.4%) | $27.44 M(+35.7%) |
| Sep 2001 | - | $20.22 M(+34.9%) |
| Jun 2001 | - | $14.99 M(+649.9%) |
| Mar 2001 | - | $2.00 M(-78.6%) |
| Dec 2000 | $9.35 M(+23.1%) | $9.35 M(+0.8%) |
| Sep 2000 | - | $9.27 M(+610.1%) |
| Jun 2000 | - | $1.31 M(-21.8%) |
| Mar 2000 | - | $1.67 M |
| Dec 1999 | $7.60 M(+327.2%) | - |
| Dec 1998 | $1.78 M(-96.7%) | - |
| Dec 1997 | $53.28 M(+489.9%) | - |
| Dec 1996 | $9.03 M | - |
FAQ
- What is Idera Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Idera Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Idera Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of IDRA is $549.00 K
What is the all time high annual total long term liabilities for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual total long term liabilities is $126.54 M
What is Idera Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, IDRA annual total long term liabilities has changed by -$126.00 M (-99.57%)
What is Idera Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of IDRA is $63.68 M
What is the all time high quarterly long term liabilities for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly total long term liabilities is $126.54 M
What is Idera Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, IDRA quarterly total long term liabilities has changed by +$63.08 M (+10461.03%)